The hemorrhagic complication is generally considered one of the most serious adverse effects with any administered dose of aspirin.
After die thrombolytic therapy, hemorrhagic adverse effects, including intracranial bleeding, did not develop.
Our nine-year-old patient with acute hemorrhagic tamponade had an angiosarcoma which invaded the right and the left atrium together with the pericardium.
Half of these malformations occur in combination with hereditary hemorrhagic teleangiectases,5 which were not present in our patient.
Other complications were hemorrhagic episodes (4), cardiac stun (13), multiple organ failure (4).
During the thrombolytic therapy no adverse reactions and no serious hemorrhagic complications were observed.
There have been no endocarditis, no thromboembolic episode and no hemorrhagic complication.
There have been no thromboembolic or hemorrhagic episodes.
